Reinsurance Group Of America Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
12.3%projected annual EPS growth
Analyst Coverage
9analysts covering
FY Revenue (est.)
$26.9Bnext fiscal year
FY EPS (est.)
$28.18next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 29 Oct 2026 |
Monitoring Framework
Key Performance Indicators
Adjusted Operating Return on Equity (ROE) Quarterly14.7Target: 13% to 15%
Annual Premium Equivalents Growth Rate AnnuallyTarget: 40% by 2030
Average Investment Portfolio Yield Quarterly493.0%Target: Outperform existing portfolio yield via higher new money rates
Non-Traditional and Financial Solutions Revenue Share Annually2,800.0%Target: 40% by 2030
Watch Items
- U.S. Group Health Segment TurnaroundTrigger: Earnings alignment with historical norms post-repricingAction: Monitor quarterly underwriting margins and claims experience in the U.S. Group business to confirm the reversal of previous headwinds.
- Capital Deployment into In-Force Block TransactionsTrigger: Deployment pace relative to the $3.4 billion deployable capital poolAction: Track the execution and integration of large-scale transactions (such as the Equitable deal) and their subsequent contribution to operating earnings.
- Asia-Pacific and EMEA Growth ExecutionTrigger: APAC new business premium CAGR falling below 8-10% target through 2027Action: Review regional premium volume growth and product development progress to ensure international diversification remains on track.
Research as of 2 Sep 2026